
Medtronic (MDT) Stock Forecast & Price Target
Medtronic (MDT) Analyst Ratings
Bulls say
Medtronic is a strong and stable medical-device company with a positive outlook due to its diverse portfolio, international market presence, and promising pipeline. The company's projected revenue growth and potential investment opportunities make it an attractive choice for investors. However, there are some potential risks to consider, such as inconsistent execution and competition in the market. Overall, Medtronic's strong financial performance and potential for further growth make it a favorable stock for investment in the long term.
Bears say
Medtronic is facing potential headwinds in the upcoming years, including market share loss in key product categories and unsuccessful new product launches, which could lead to revenue growth slowing to less than 5%. Additionally, macroeconomic volatility could impact the company's operations and revenue growth, and there is risk of slower earnings growth and ROIC expansion if management fails to prudently allocate capital at accretive returns. With a negative outlook, our forecasted price target is lower than the current share price.
This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.
Medtronic (MDT) Analyst Forecast & Price Prediction
Start investing in Medtronic (MDT)
Order type
Buy in
Order amount
Est. shares
0 shares